| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Richard D. Thrasher | |
| Todd T. Kingdom | |||
| P2860 | cites work | Blastomyces dermatitidis | Q3012311 |
| Agents for treatment of invasive fungal infections | Q33874835 | ||
| Allergic fungal rhinosinusitis: pathophysiology, epidemiology, and diagnosis | Q33874872 | ||
| Allergic fungal rhinosinusitis: perioperative management, prevention of recurrence, and role of steroids and antifungal agents. | Q33874884 | ||
| Eosinophilic mucin rhinosinusitis: a distinct clinicopathological entity | Q33916466 | ||
| Medical treatment of allergic fungal sinusitis | Q34029410 | ||
| Allergic fungal rhinosinusitis: current theories and management strategies | Q34280591 | ||
| Oral candidiasis. History, classification, and clinical presentation | Q34324153 | ||
| A new classification and diagnostic criteria for invasive fungal sinusitis | Q38555167 | ||
| In vitro effectiveness of 13 agents in otomycosis and review of the literature | Q39536234 | ||
| Allergic fungal sinusitis: the Mayo Clinic experience | Q40695578 | ||
| Fungal sinusitis: an update | Q40966220 | ||
| Antifungal activity against allergic fungal sinusitis organisms | Q41208009 | ||
| Allergic fungal sinusitis in the pediatric population | Q41258373 | ||
| Immunotherapy in the treatment of allergic fungal sinusitis | Q41338723 | ||
| Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis | Q43955406 | ||
| Case report: candida infection presenting as laryngitis | Q45144725 | ||
| Allergic fungal sinusitis: problems in diagnosis and treatment | Q46807882 | ||
| Allergic bronchopulmonary aspergillosis with obstruction of the upper respiratory tract | Q68209790 | ||
| Histoplasmosis of the Larynx | Q69595915 | ||
| Allergic fungal sinusitis presenting as a paranasal sinus tumour | Q69734520 | ||
| Otomycosis in Burma, and its treatment | Q70530601 | ||
| The prevalence and intra-oral distribution of Candida albicans in man | Q72147639 | ||
| Otomycosis: A Clinical Entity—Clinical and Experimental Study | Q72288985 | ||
| The diagnosis and incidence of allergic fungal sinusitis | Q72995810 | ||
| Outcomes after discontinuing immunotherapy for allergic fungal sinusitis | Q73341553 | ||
| Chronic invasive fungal rhinosinusitis | Q73590959 | ||
| Fungus balls of the paranasal sinuses | Q73590963 | ||
| Geographic variation in allergic fungal rhinosinusitis | Q73590972 | ||
| Evaluation and treatment of allergic fungal sinusitis. I. Demographics and diagnosis | Q77398086 | ||
| Evaluation and treatment of allergic fungal sinusitis. II. Treatment and follow-up | Q77398090 | ||
| Further evidence for allergic pathophysiology in allergic fungal sinusitis | Q77431092 | ||
| Immunotherapy for allergic fungal sinusitis: three years' experience | Q77679705 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 577-594 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Otolaryngologic Clinics of North America | Q4626829 |
| P1476 | title | Fungal infections of the head and neck: an update | |
| P478 | volume | 36 |
| Q35502577 | Allergic Aspergillus sinusitis and its association with allergic bronchopulmonary aspergillosis |
| Q51626901 | Allergic fungal rhino sinusitis with granulomas: A new entity? |
| Q55411220 | Analysis of differential expression of protease-activated receptors in patients with allergic fungal rhinosinusitis. |
| Q64039517 | Fungal Rhinosinusitis: Unravelling the Disease Spectrum |
| Q37882404 | Fungal infections of the ear in immunocompromised host: a review |
| Q35879467 | Mold and mycotoxins: effects on the neurological and immune systems in humans |
| Q35729264 | Nasal manifestations of systemic illnesses |
| Q38861962 | Otomycosis in a Rural Community Attending a Tertiary Care Hospital: Assessment of Risk Factors and Identification of Fungal and Bacterial Agents. |
Search more.